Dec. 19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease in a subset of people.

Research on Alzheimer’s disease is approaching a much-needed tipping point. The media spotlight has been on newly available drugs like lecanemab and donanemab that target the protein plaques ...

While nearly 7 million Americans aged 65 and older suffer from Alzheimer's disease, experts are reflecting on the advances in diagnosis, treatment and risk management that have been made in 2024.

The “crisis will only worsen” because of the ageing population, Alzheimer’s Research UK warned, unless the Government takes action. It added that the upcoming 10-Year Health Plan should be ...

A doctor who says he's as healthy as someone 20 years his junior believes walking is a key part of his daily routine.

Dec. 19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease in a subset of people.

China's medical regulator has approved Eli Lilly's treatment for early Alzheimer's, providing patients with another option ...

We have entered a new era of improved and emerging biologically-based diagnostic biomarkers for Alzheimer's disease (AD) and AD-related neurodegenerative disorders (ADRD) that are rapidly ...

The UK medicines regulator approved Eli Lilly's Alzheimer's disease therapy Kisunla today, but the drug is too expensive to be funded by the NHS, according to cost-effectiveness watchdog NICE.

Dementia robs us of everything that matters. Our memories, our connections, our story. And our latest analysis reveals the devastating scale at which it is claiming lives across the UK – more than any ...

The success of VU319 exemplifies how collaboration and innovation can bring real hope to patients and families facing Alzheimer's and other neurodegenerative diseases." Cybele Raver, Provost and ...